-
Sector Analysis
NewBronchiectasis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033
This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, China) and provides an Excel-based forecast model for the bronchiectasis market through 2033. Insomnia, currently represented in the International Classification of Sleep Disorders (Third Edition; ICSD-3) and the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition; DSM-5), is defined as patient-reported difficulty with sleep initiation or sleep maintenance, despite adequate opportunity and circumstances for sleep. It can include frequent awakenings, difficulty returning to sleep after awakening, or...
-
Product Insights
NewAirway Management Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Airway Management Pipeline Market Report Overview Airway management refers to medical procedures performed for the prevention or alleviation of any obstruction in the airway. Airway management procedures are performed to open a pathway for maintaining or re-storing proper gas exchange between a patient's lungs and the atmosphere. This is accomplished with the use of an infraglottic device (Endotracheal tubes) supraglottic device (Laryngeal mask) or surgical method (Tracheostomy). The devices used for airway management are referred to as airway management devices....
-
Product Insights
NewEndotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Endotracheal Tubes Pipeline Market Report Overview Endotracheal tubes are used to maintain an unobstructed passageway especially to deliver oxygen or anesthesia to the lungs during surgery or any airway management procedure. The curved tube is placed through the patient's nose or mouth into the trachea (windpipe). The endotracheal tubes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Sector Analysis
NewAntibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products, Opportunities and Challenges
Antibody-Drug Conjugates Market Report Overview An Antibody-Drug Conjugates (ADC) drug consists of monoclonal antibodies conjugated to a payload via a linker, for the precise targeting of antigen-positive cancer cells. ADCs are developed to target protein receptors with high expression such as HER2, TROP-2, CD22, and others. There are two cytotoxic payload types predominantly used in ADCs including microtubule inhibitors, and the more potent DNA-damaging payloads such as topoisomerase I inhibitors. The ADC market research report will aid clients in gaining...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Semzuvolimab in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Semzuvolimab in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Semzuvolimab in Human Immunodeficiency Virus (HIV) Infections (AIDS)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Neratinib in Gallbladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Neratinib in Gallbladder Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neratinib in Gallbladder Cancer Drug Details: Neratinib (Nerlynx) is a member...
-
Sector Analysis
Ovarian Cancer Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Ovarian Cancer Market Report Overview The ovarian cancer market across the 7MM was valued at $3.3 billion in 2022. The market will grow at a CAGR of more than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Ovarian cancer is one of the most lethal gynecological cancers worldwide. Approximately 90% of ovarian cancer cases are epithelial, with distinct sites of origin arising from the ovarian surface epithelium or distal fallopian...
-
Product Insights
Esophageal Diseases – Drugs In Development, 2023
Global Markets Direct’s, ‘Esophageal Diseases - Drugs In Development, 2023’, provides an overview of the Esophageal Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Esophageal Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Allergic Rhinitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Allergic Rhinitis - Drugs In Development, 2023’, provides an overview of the Allergic Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Allergic Rhinitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Simplexvirus (HSV) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Simplexvirus (HSV) Infections - Drugs In Development, 2023’, provides an overview of the Simplexvirus (HSV) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Simplexvirus (HSV) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...